The scientist’s investigation covers issues in Klebsiella pneumoniae, Microbiology, Carbapenem, Imipenem and Antibacterial agent. Her work carried out in the field of Klebsiella pneumoniae brings together such families of science as Gentamicin, Virology, Colistin, Internal medicine and Drug resistance. Her Microbiology research is multidisciplinary, incorporating elements of Molecular epidemiology, Enterobacteriaceae, Outbreak and Infection control.
While the research belongs to areas of Carbapenem, Andrea Endimiani spends her time largely on the problem of Ertapenem, intersecting her research to questions surrounding Biapenem. Her research combines Meropenem and Imipenem. Her research in Meropenem intersects with topics in Antimicrobial, Pharmacology, Thienamycin and Intensive care medicine.
Andrea Endimiani mostly deals with Microbiology, Klebsiella pneumoniae, Enterobacteriaceae, Escherichia coli and Cephalosporin. She interconnects Plasmid and Multilocus sequence typing in the investigation of issues within Microbiology. The various areas that Andrea Endimiani examines in her Klebsiella pneumoniae study include Antibacterial agent, Virology, Carbapenem, Internal medicine and Drug resistance.
Her research investigates the connection with Carbapenem and areas like Ertapenem which intersect with concerns in Doripenem. The Drug resistance study combines topics in areas such as Acinetobacter baumannii and Infection control, Intensive care medicine. Her studies deal with areas such as Veterinary medicine, Proteus mirabilis and Colonization as well as Cephalosporin.
Andrea Endimiani mainly focuses on Microbiology, Plasmid, Antibiotic resistance, Escherichia coli and Multilocus sequence typing. Andrea Endimiani is studying Multiple drug resistance, which is a component of Microbiology. As a member of one scientific family, Andrea Endimiani mostly works in the field of Antibiotic resistance, focusing on Infection control and, on occasion, Moraxellaceae, Pneumonia, Acinetobacter baumannii, Acinetobacter and Intensive care.
In the field of Escherichia coli, her study on Carbapenemase producing overlaps with subjects such as Transmission and Fish <Actinopterygii>. Her Multilocus sequence typing study combines topics in areas such as Medical microbiology and Internal medicine. Andrea Endimiani combines subjects such as Drug resistance, Colistin, Colonization and Cephalosporin with her study of Enterobacteriaceae.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Carbapenems: Past, Present, and Future
Krisztina M. Papp-Wallace;Andrea Endimiani;Andrea Endimiani;Andrea Endimiani;Magdalena A. Taracila;Robert A. Bonomo.
Antimicrobial Agents and Chemotherapy (2011)
THE CONTINUING CHALLENGE OF ESBLS
Federico Perez;Andrea Endimiani;Andrea Endimiani;Kristine M. Hujer;Robert A. Bonomo;Robert A. Bonomo.
Current Opinion in Pharmacology (2007)
Extended-spectrum cephalosporin-resistant Gram-negative organisms in livestock: an emerging problem for human health?
Salome Nadja Seiffert;Markus Hilty;Markus Hilty;Vincent Perreten;Andrea Endimiani.
Drug Resistance Updates (2013)
Transmission Dynamics of Extended-Spectrum β-lactamase–Producing Enterobacteriaceae in the Tertiary Care Hospital and the Household Setting
Markus Hilty;Belinda Y. Betsch;Katja Bögli-Stuber;Nadja Heiniger.
Clinical Infectious Diseases (2012)
Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA
Andrea Endimiani;Andrea M. Hujer;Federico Perez;Christopher R. Bethel.
Journal of Antimicrobial Chemotherapy (2009)
Outbreak of Colistin-Resistant, Carbapenem-Resistant Klebsiella pneumoniae in Metropolitan Detroit, Michigan
Dror Marchaim;Teena Chopra;Jason M. Pogue;Federico Perez.
Antimicrobial Agents and Chemotherapy (2011)
Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination
Federico Perez;Andrea Endimiani;Andrea Endimiani;Amy J. Ray;Brooke K. Decker.
Journal of Antimicrobial Chemotherapy (2010)
Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections
Elizabeth A. Neuner;Jun Yen Yeh;Gerri S. Hall;Jennifer Sekeres.
Diagnostic Microbiology and Infectious Disease (2011)
In Vitro Activity of Fosfomycin against blaKPC-Containing Klebsiella pneumoniae Isolates, Including Those Nonsusceptible to Tigecycline and/or Colistin
Andrea Endimiani;Andrea Endimiani;Gopi Patel;Kristine M. Hujer;Kristine M. Hujer;Mahesh Swaminathan.
Antimicrobial Agents and Chemotherapy (2010)
IMP-12, a New Plasmid-Encoded Metallo-β-Lactamase from a Pseudomonas putida Clinical Isolate
Jean Denis Docquier;Maria Letizia Riccio;Claudia Mugnaioli;Francesco Luzzaro.
Antimicrobial Agents and Chemotherapy (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: